rs143714496

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001206927.2(DNAH8):​c.13381C>T​(p.Arg4461Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00304 in 1,602,132 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 10 hom. )

Consequence

DNAH8
NM_001206927.2 missense

Scores

4
7
7

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.88

Publications

3 publications found
Variant links:
Genes affected
DNAH8 (HGNC:2952): (dynein axonemal heavy chain 8) The protein encoded by this gene is a heavy chain of an axonemal dynein involved in sperm and respiratory cilia motility. Axonemal dyneins generate force through hydrolysis of ATP and binding to microtubules. [provided by RefSeq, Jan 2012]
DNAH8 Gene-Disease associations (from GenCC):
  • spermatogenic failure 46
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • spermatogenic failure 5
    Inheritance: AR Classification: MODERATE Submitted by: Franklin by Genoox
  • primary ciliary dyskinesia
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012955099).
BP6
Variant 6-39012224-C-T is Benign according to our data. Variant chr6-39012224-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 414397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00198 (301/152218) while in subpopulation NFE AF = 0.00315 (214/68010). AF 95% confidence interval is 0.0028. There are 1 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH8NM_001206927.2 linkc.13381C>T p.Arg4461Cys missense_variant Exon 90 of 93 ENST00000327475.11 NP_001193856.1 Q96JB1Q8IU65A0A075B6F3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH8ENST00000327475.11 linkc.13381C>T p.Arg4461Cys missense_variant Exon 90 of 93 5 NM_001206927.2 ENSP00000333363.7 A0A075B6F3
DNAH8ENST00000359357.7 linkc.12730C>T p.Arg4244Cys missense_variant Exon 88 of 91 2 ENSP00000352312.3 Q96JB1-1

Frequencies

GnomAD3 genomes
AF:
0.00197
AC:
300
AN:
152100
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000411
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00315
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00180
AC:
444
AN:
246350
AF XY:
0.00182
show subpopulations
Gnomad AFR exome
AF:
0.000372
Gnomad AMR exome
AF:
0.00135
Gnomad ASJ exome
AF:
0.00433
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00113
Gnomad NFE exome
AF:
0.00280
Gnomad OTH exome
AF:
0.00217
GnomAD4 exome
AF:
0.00315
AC:
4562
AN:
1449914
Hom.:
10
Cov.:
30
AF XY:
0.00310
AC XY:
2232
AN XY:
720074
show subpopulations
African (AFR)
AF:
0.000482
AC:
16
AN:
33188
American (AMR)
AF:
0.00121
AC:
53
AN:
43798
Ashkenazi Jewish (ASJ)
AF:
0.00411
AC:
106
AN:
25816
East Asian (EAS)
AF:
0.0000506
AC:
2
AN:
39510
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85182
European-Finnish (FIN)
AF:
0.00110
AC:
58
AN:
52870
Middle Eastern (MID)
AF:
0.00110
AC:
6
AN:
5442
European-Non Finnish (NFE)
AF:
0.00380
AC:
4191
AN:
1104224
Other (OTH)
AF:
0.00217
AC:
130
AN:
59884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
184
368
551
735
919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00198
AC:
301
AN:
152218
Hom.:
1
Cov.:
33
AF XY:
0.00179
AC XY:
133
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41514
American (AMR)
AF:
0.00294
AC:
45
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00315
AC:
214
AN:
68010
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00274
Hom.:
1
Bravo
AF:
0.00182
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00302
AC:
26
ExAC
AF:
0.00156
AC:
189
EpiCase
AF:
0.00268
EpiControl
AF:
0.00332

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jan 18, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2017
UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DNAH8-related disorder Benign:1
Jan 31, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.060
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T;T
Eigen
Pathogenic
0.92
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.066
D
MetaRNN
Benign
0.013
T;T
MetaSVM
Benign
-0.77
T
MutationAssessor
Pathogenic
3.3
.;M
PhyloP100
1.9
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-6.9
.;D
REVEL
Uncertain
0.32
Sift
Uncertain
0.018
.;D
Polyphen
1.0
.;D
Vest4
0.47
MVP
0.69
MPC
0.65
ClinPred
0.10
T
GERP RS
6.2
Varity_R
0.41
gMVP
0.70
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143714496; hg19: chr6-38980000; API